Quantcast
Last updated on April 19, 2014 at 8:45 EDT

Baxter Recalls Gammagard Liquid 10%, 20g: You Can Still File a Claim for Gammagard Adverse Events

April 7, 2012

On March 14th, 2012 Baxter announced the voluntary recall of specific Lot of Gammagard Liquid [Immune Globulin Intravenous (Human)] 10%, 20g size as a precautionary measure due to a labeling error noted on the product vial label and unit carton. Gammagard, manufactured by Baxter, is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body to maintain immunity and fight disease. In February 1994, Baxter announced it was removing Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Gammagard severe adverse events (http://www.attorneyone.com/gammagard-lawsuits).

San Diego, CA (PRWEB) April 06, 2012

The media spotlight is often a double-edged sword. No one knows this better than patients who suffer from Gammagard severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

On March 14th, 2012 Baxter announced the voluntary Gammagard Recall of Lot LE12LG70AC of Gammagard Liquid [Immune Globulin Intravenous (Human)] 10%, 20g size, Product Code 1502797, NDC # 0944-2700-06 as a precautionary measure due to a labeling error noted on the product vial label and unit carton.

Gammagard, manufactured by Baxter, is an intravenous solution that is made from human plasma. It is a sterile solution, which helps the body to maintain immunity and fight disease. Gammagard is used to treat primary immune deficiency disorders, and to reduce the risk of infection in individuals with poorly functioning immune systems including those with chronic lymphocytic leukemia.

In February 1994, Baxter announced it was removing Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. In July 1995, the FDA said that as many as 1,000 cases of hepatitis C could have been linked to use of Gammagard.

In September 2000, the U.S.D.C. for the Central District of California approved a settlement of the class action (MDL NO. 95-1060-R) providing financial compensation for U.S. individuals who used Gammagard between January 1993 and February 1994. According to the settlement, the number of patients receiving Gammagard during this period is not known but is estimated to be several thousand.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of in case of Gammagard severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse events from Gammagard remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On May 27th, 2010 Baxter issued a market withdrawal of specific lots of the Gammagard Liquid. The FDA said this voluntary withdrawal was a precautionary measure due to an increased number of adverse effects reports of allergic reactions related to specific lots.

If you have recently been diagnosed with Hepatitis C and you took Gammagard, you might be able to file a Gammagard lawsuit.

AttorneyOne.com has further information on Gammagard lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Gammagard at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/4/prweb9367732.htm.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/4/prweb9375513.htm


Source: prweb